Skip to main content

Table 1 Correlations between STOML2 expression and clinicopathological parameters of CRC patients

From: STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation

  

STOML2 expression

p value*

Variables

All cases

(n = 215)

Low (%)

(n = 86)

High (%)

(n = 129)

Sex

   

0.569

Male

132

55 (33.8)

77 (66.2)

 

Female

83

31 (34.9)

52 (65.1)

 

Age

   

0.405

< 61

103

38 (35.6)

65 (64.4)

 

≥61

112

48 (32.8)

64 (67.2)

 

Differentiation

   

0.085

Well

81

40 (37.0)

41 (63.0)

 

Moderate

105

37 (36.2)

68 (63.8)

 

Poor and undifferentiated

29

9 (28.1)

20 (71.9)

 

T stage

   

0.026

T1 + T2

30

18 (55.0)

12 (45.0)

 

T3 + T4

185

68 (29.9)

117 (70.1)

 

Lymph node metastasis

   

< 0.0001

Absent (N0)

114

62 (52.0)

52 (48.0)

 

Present (N1–2)

101

24 (20.9)

77 (79.1)

 

Distant metastasis

   

0.008

Absent (M0)

168

60(38.2)

108 (61.8)

 

Present (M1)

23

2 (6.7)

21 (93.3)

 

AJCC classification

   

< 0.0001

I

24

15

9

 

II

88

47

41

 

III

80

22

58

 

IV

23

2

21

 
  1. *p values of Sex, Age, Differentiation, T stage, Lymph node metastasis, Distant metastasis, AJCC classification, were calculated by χ2 test
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us